Search Results

You are looking at 91 - 100 of 517 items for :

  • Refine by Access: All x
Clear All
Full access

Brian Seal, Candice Yong, M. Janelle Cambron-Mellott, Oliver Will, Martine C. Maculaitis, Kelly Clapp, Emily Mulvihill, Ion Cotarla, and Ranee Mehra

%, and all G neuropathy from 5% to 39%, if OS increased by 17, 4, and 2 months, respectively. In addition, pts would require an increase in OS of 1 month to accept an increase in G3/4 fatigue from 1% to 12% or all G pneumonitis from <1% to 8%. Preferences

Full access

Ping Jiang, Ang Qu, Weijuan Jiang, Xiuwen Deng, and Junjie Wang

twice a week. Dose escalation followed a 3 + 3 design. The DLT was defined as grade 3 or 4 nonhematologic toxicity, excluding nausea, vomiting and alopecia, decreased appetite and fatigue, or grade 4 hematologic toxicity. Results : This study was

Full access

John Mascarenhas, Arianna Kee, Hiep Nguyen, Ashley Saunders, Louisa Oliver, Hannah Tomkinson, Richard Perry, and Ali McBride

consensus statements suggest patient-reported symptoms of fatigue, poor concentration, inactivity, and bone pain were too general to define RUX failure compared with other specific MF symptoms ie, night sweats. Following RUX failure, consensus

Full access

Pam Baker DeGuzman, Veronica Bernacchi, C. Allen Cupp, B. J. Ferrebee Ghamandi, Ivora D. Hinton, Mark J. Jameson, Debra Lynn Lewandowski, and Christi Sheffield

16 participants, the most common issues identified were fatigue (69%), worry (63%), family health issues (56%) and hearing loss (56%). Although only 3 participants identified jaw swelling as an issue, this was the most highly rated area of distress on

Full access

Sonali Agrawal, Caitlin R. Meeker, Sandeep Aggarwal, Elizabeth A. Handorf, Sunil Adige, Efrat Dotan, Crystal S. Denlinger, William H. Ward, Jeffrey M. Farma, and Namrata Vijayvergia

(others were on clinical trials with novel agents). Most common grade 3+ tox reported by providers included nausea (10%) and neuropathy (8%), while the common clinically significant tox reported by pts were neuropathy (20%), fatigue (20%), and anxiety (15

Full access

Karen Wonders, Jay K Harness, and Arthur G Lerner

Specifically, cardiovascular endurance, muscular strength, quality of life, depression, fear, fatigue, and pain all significantly improved following the exercise intervention (p<0.05). On average, each patient exhibited 2.81 fewer encounters following exercise

Full access

Muhammad Zain Farooq, Mishal Shan Siddiqui, Syed Ali Farhan, Mahima Khatri, Syed Hamza Bin Waqar, Saad Khalid, and Ankit Mangla

, diarrhea and fatigue. Serious adverse events are only rarely reported, and most of the toxicities are relatively nonthreatening and manageable.

Full access

Ernesto Munoz and Allison Carilli

, fatigue, and CNS involvement. This case illustrates a patient with disease involvement of the muscles of the forearm causing compartment syndrome. This is a rare presentation that have not been described in the literature to this date.

Full access

Luke Proctor, Arjith Rathakrishnan, Claudia Zapata, and KanwarAnoop Kainaur

survival of < 20%. Methods: Case report demonstrating diagnosis and clinical management of a patient with pediatric metastatic pulmonary adenocarcinoma . Results: A 14-year-old male presented with persistent emesis, weight loss, and fatigue despite

Full access

Karl D. Lewis, Timothy J. Inocencio, Ruben G.W. Quek, Patrick R. LaFontaine, Zeynep Eroglu, Anne Lynn S. Chang, Cristina Ivanescu, Alexander J. Stratigos, Ketty Peris, Aleksandar Sekulic, Matthew G. Fury, and Chieh-I Chen

(∼1 year of treatment), with consistent results at Cycle 9 except for fatigue. On the Skindex-16, overall changes from baseline showed maintenance on emotional, symptom, and functional subscales. Responder analysis showed clinically meaningful